Concepts (89)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Longevity | 6 | 2020 | 147 | 1.530 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2020 | 767 | 1.220 |
Why?
|
| Telomerase | 4 | 2016 | 44 | 0.640 |
Why?
|
| Leukocytes | 1 | 2018 | 72 | 0.630 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 4 | 2016 | 84 | 0.610 |
Why?
|
| Telomere | 3 | 2016 | 56 | 0.550 |
Why?
|
| Genome-Wide Association Study | 1 | 2018 | 333 | 0.540 |
Why?
|
| Embryonic Stem Cells | 2 | 2011 | 59 | 0.460 |
Why?
|
| Pluripotent Stem Cells | 1 | 2009 | 32 | 0.330 |
Why?
|
| Signal Transduction | 1 | 2018 | 1908 | 0.330 |
Why?
|
| Cell Hypoxia | 3 | 2016 | 58 | 0.250 |
Why?
|
| Japan | 3 | 2020 | 305 | 0.230 |
Why?
|
| Genetic Association Studies | 2 | 2020 | 114 | 0.210 |
Why?
|
| Coronary Disease | 1 | 2020 | 124 | 0.170 |
Why?
|
| Genotype | 2 | 2018 | 730 | 0.170 |
Why?
|
| Heterozygote | 1 | 2018 | 93 | 0.160 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 2379 | 0.160 |
Why?
|
| Hydra | 1 | 2018 | 4 | 0.160 |
Why?
|
| Alleles | 1 | 2018 | 321 | 0.150 |
Why?
|
| Sirtuin 3 | 1 | 2016 | 6 | 0.150 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2016 | 7 | 0.150 |
Why?
|
| Sirtuin 1 | 1 | 2016 | 32 | 0.140 |
Why?
|
| Pre-Eclampsia | 1 | 2016 | 61 | 0.130 |
Why?
|
| Encephalitis | 1 | 2016 | 42 | 0.130 |
Why?
|
| Coronary Artery Disease | 1 | 2017 | 142 | 0.130 |
Why?
|
| Germ Cells | 1 | 2016 | 73 | 0.130 |
Why?
|
| Animals | 6 | 2018 | 15081 | 0.130 |
Why?
|
| Transfection | 1 | 2016 | 523 | 0.130 |
Why?
|
| Mice | 5 | 2016 | 5913 | 0.120 |
Why?
|
| Stem Cells | 1 | 2016 | 141 | 0.120 |
Why?
|
| Monocytes | 1 | 2016 | 257 | 0.120 |
Why?
|
| Hypertension | 1 | 2020 | 796 | 0.110 |
Why?
|
| Humans | 8 | 2020 | 37093 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 643 | 0.110 |
Why?
|
| Aging | 1 | 2018 | 664 | 0.110 |
Why?
|
| Aged | 3 | 2020 | 6741 | 0.110 |
Why?
|
| Nanoparticles | 1 | 2016 | 318 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2011 | 54 | 0.090 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 2721 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 173 | 0.090 |
Why?
|
| RNA Interference | 1 | 2010 | 243 | 0.080 |
Why?
|
| Male | 5 | 2020 | 20025 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 515 | 0.080 |
Why?
|
| Young Adult | 1 | 2018 | 4268 | 0.080 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 578 | 0.070 |
Why?
|
| Middle Aged | 2 | 2018 | 10129 | 0.070 |
Why?
|
| Female | 4 | 2018 | 20969 | 0.070 |
Why?
|
| Mice, Knockout | 1 | 2009 | 933 | 0.070 |
Why?
|
| Adult | 2 | 2018 | 11712 | 0.070 |
Why?
|
| Models, Biological | 1 | 2009 | 677 | 0.060 |
Why?
|
| Cell Proliferation | 1 | 2011 | 1198 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 1015 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 2 | 2016 | 1609 | 0.040 |
Why?
|
| Phenotype | 1 | 2020 | 689 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2020 | 753 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 885 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1130 | 0.040 |
Why?
|
| Age Factors | 1 | 2020 | 1033 | 0.040 |
Why?
|
| Sex Factors | 1 | 2020 | 898 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2019 | 448 | 0.040 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2016 | 11 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 628 | 0.040 |
Why?
|
| Trophoblasts | 1 | 2016 | 24 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 2019 | 474 | 0.040 |
Why?
|
| Adoptive Transfer | 1 | 2016 | 48 | 0.030 |
Why?
|
| Placenta | 1 | 2016 | 97 | 0.030 |
Why?
|
| Ovum | 1 | 2016 | 35 | 0.030 |
Why?
|
| Gestational Age | 1 | 2016 | 190 | 0.030 |
Why?
|
| Prevalence | 1 | 2020 | 1455 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 189 | 0.030 |
Why?
|
| Ovary | 1 | 2016 | 108 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2016 | 208 | 0.030 |
Why?
|
| Testis | 1 | 2016 | 187 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 623 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2016 | 162 | 0.030 |
Why?
|
| Spermatozoa | 1 | 2016 | 200 | 0.030 |
Why?
|
| Hawaii | 1 | 2020 | 1929 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2016 | 859 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2017 | 1378 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2016 | 587 | 0.030 |
Why?
|
| Cytokines | 1 | 2016 | 602 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2016 | 1207 | 0.020 |
Why?
|
| Pregnancy | 1 | 2016 | 1549 | 0.020 |
Why?
|
| Homeostasis | 1 | 2010 | 188 | 0.020 |
Why?
|
| Risk Factors | 1 | 2017 | 3562 | 0.020 |
Why?
|
| Base Sequence | 1 | 2010 | 997 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 1568 | 0.020 |
Why?
|
| United States | 1 | 2017 | 4223 | 0.020 |
Why?
|
| Cell Line | 1 | 2010 | 1354 | 0.020 |
Why?
|